Found: 67
Select item for more details and to access through your institution.
Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01069-6
- By:
- Publication type:
- Article
Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0939-5
- By:
- Publication type:
- Article
Renal glucosuria is associated with lower body weight and lower rates of elevated systolic blood pressure: results of a nationwide cross-sectional study of 2.5 million adolescents.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0929-7
- By:
- Publication type:
- Article
Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0925-y
- By:
- Publication type:
- Article
Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0836-y
- By:
- Publication type:
- Article
Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12933-018-0796-7
- By:
- Publication type:
- Article
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12933-018-0766-0
- By:
- Publication type:
- Article
Correction: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01810-x
- By:
- Publication type:
- Article
Leiomyosarcoma of the Right Atrium Masked by a Covering Thrombus: Conflicting Results of Echocardiography and Transvenous Biopsy-In Favor of Echocardiography.
- Published in:
- Echocardiography, 1997, v. 14, n. 6, p. 607, doi. 10.1111/j.1540-8175.1997.tb00769.x
- By:
- Publication type:
- Article
Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035298
- By:
- Publication type:
- Article
Echocardiographic evaluation of the effects of gallopamil on left ventricular function.
- Published in:
- Clinical Pharmacology & Therapeutics, 1988, v. 44, n. 1, p. 100, doi. 10.1038/clpt.1988.119
- By:
- Publication type:
- Article
Bezafibrate and Simvastatin: Different Beneficial Effects for Different Therapeutic Aims.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 4, p. 1978, doi. 10.1210/jc.2003-032038
- By:
- Publication type:
- Article
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.
- Published in:
- European Heart Journal, 2005, v. 26, n. 19, p. 2032, doi. 10.1093/eurheartj/ehi310
- By:
- Publication type:
- Article
Usefulness of Immediate Postexercise Two-Dimensional Echocardiography in Post-Myocardial Infarction Patients Without Ischemic ECG Changes in Stress Testing: Comparison with Radionuclide Angiography.
- Published in:
- Angiology, 1989, v. 40, n. 7, p. 605, doi. 10.1177/000331978904000701
- By:
- Publication type:
- Article
Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0582-y
- By:
- Publication type:
- Article
Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0573-z
- By:
- Publication type:
- Article
The addition of vildagliptin to metformin prevents the elevation of interleukin 1β in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0551-5
- By:
- Publication type:
- Article
Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0478-2
- By:
- Publication type:
- Article
Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0466-6
- By:
- Publication type:
- Article
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0332-6
- By:
- Publication type:
- Article
Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0282-4
- By:
- Publication type:
- Article
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0294-0
- By:
- Publication type:
- Article
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 159, doi. 10.1186/s12933-014-0159-y
- By:
- Publication type:
- Article
Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1475-2840-13-103
- By:
- Publication type:
- Article
Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-161
- By:
- Publication type:
- Article
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
- Published in:
- Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 140, doi. 10.1186/1475-2840-11-140
- By:
- Publication type:
- Article
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
- Published in:
- Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 125, doi. 10.1186/1475-2840-11-125
- By:
- Publication type:
- Article
"The metabolic syndrome... is dead": These reports are an exaggeration.
- Published in:
- Cardiovascular Diabetology, 2011, v. 10, n. 1, p. 11, doi. 10.1186/1475-2840-10-11
- By:
- Publication type:
- Article
The ubiquitous interleukin-6: a time for reappraisal.
- Published in:
- Cardiovascular Diabetology, 2010, v. 9, p. 62, doi. 10.1186/1475-2840-9-62
- By:
- Publication type:
- Article
"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
- Published in:
- Cardiovascular Diabetology, 2010, v. 9, p. 24, doi. 10.1186/1475-2840-9-24
- By:
- Publication type:
- Article
Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients wit advanced functional capacity impairment.
- Published in:
- Cardiovascular Diabetology, 2009, v. 8, p. 1, doi. 10.1186/1475-2840-8-5
- By:
- Publication type:
- Article
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
- Published in:
- Cardiovascular Diabetology, 2008, v. 7, p. 1, doi. 10.1186/1475-2840-7-18
- By:
- Publication type:
- Article
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins.
- Published in:
- Cardiovascular Diabetology, 2006, v. 5, p. 20, doi. 10.1186/1475-2840-5-20
- By:
- Publication type:
- Article
Statins research unfinished saga: desirability versus feasibility.
- Published in:
- Cardiovascular Diabetology, 2005, v. 4, p. 8, doi. 10.1186/1475-2840-4-8
- By:
- Publication type:
- Article
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
- Published in:
- Cardiovascular Diabetology, 2005, v. 4, p. 14, doi. 10.1186/1475-2840-4-14
- By:
- Publication type:
- Article
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR).
- Published in:
- Cardiovascular Diabetology, 2003, v. 2, p. 4, doi. 10.1186/1475-2840-2-4
- By:
- Publication type:
- Article
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 1, doi. 10.1186/1475-2840-3-10
- By:
- Publication type:
- Article
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2003, v. 2, p. 14, doi. 10.1186/1475-2840-2-14
- By:
- Publication type:
- Article
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.
- Published in:
- Cardiovascular Diabetology, 2003, v. 2, p. 11, doi. 10.1186/1475-2840-2-11
- By:
- Publication type:
- Article
Losartan and diabetic nephropathy: commentaries on the RENAAL study.
- Published in:
- Cardiovascular Diabetology, 2002, v. 1, p. 2, doi. 10.1186/1475-2840-1-2
- By:
- Publication type:
- Article
Functional Capacity Impairment in Patients with Coronary Artery Disease: Prevalence, Risk Factors and Prognosis.
- Published in:
- Cardiology, 2003, v. 100, n. 4, p. 207, doi. 10.1159/000074814
- By:
- Publication type:
- Article
Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension.
- Published in:
- Cardiology, 2002, v. 97, n. 1, p. 2, doi. 10.1159/000047411
- By:
- Publication type:
- Article
Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies.
- Published in:
- Cardiology, 2001, v. 95, n. 1, p. 20
- By:
- Publication type:
- Article
Attenuated Responses of Doppler-Derived Hemodynamic Parameters during Supine Bicycle Exercise in Heart Transplant Recipients.
- Published in:
- Cardiology, 1999, v. 92, n. 3, p. 204
- By:
- Publication type:
- Article
Antihyperglycemic Treatment in Diabetics with Coronary Disease: Increased Metformin-Associated Mortality over a 5-Year Follow-Up.
- Published in:
- Cardiology, 1999, v. 91, n. 3, p. 195, doi. 10.1159/000006909
- By:
- Publication type:
- Article
L-Arginine: Rediscovery in Progress.
- Published in:
- Cardiology, 1998, v. 90, n. 3, p. 153, doi. 10.1159/000006837
- By:
- Publication type:
- Article
Disrupted Mobile Aortic Plaques Are a Major Risk Factor for Systemic Embolism in the Elderly.
- Published in:
- Cardiology, 1998, v. 89, n. 4, p. 246, doi. 10.1159/000006795
- By:
- Publication type:
- Article
Persistence of Normal Right Ventricular Doppler Filling Pattern Early after Tricuspid Valve Excision.
- Published in:
- Cardiology, 1994, v. 85, n. 5, p. 352, doi. 10.1159/000176734
- By:
- Publication type:
- Article
Onset of Intolerance Symptoms during Exercise Testing Is a Reproducible Threshold for Evaluation of Cardiac Function.
- Published in:
- Cardiology, 1993, v. 83, n. 3, p. 183, doi. 10.1159/000175967
- By:
- Publication type:
- Article